Eris Lifesciences Limited (ERIS) Share Analysis
NSE · Healthcare · Pharmaceuticals
Eris Lifesciences Limited (NSE: ERIS) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 14 Nov 2026, the share price was ₹1,307.00, P/E 24.3, ROE 18.7%.
Get the AI verdict on ERIS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
ERIS chart with trendlines
Is ERIS a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Eris Lifesciences Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
ERIS key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,307.00 |
| Market cap | ₹18,136 Cr |
| P/E ratio | 24.3 |
| P/B ratio | 4.37 |
| EPS | ₹51.18 |
| Book value per share | ₹299.00 |
| Dividend yield | 0.55% |
| 52-week range | |
| 52-week high | ₹1,740.00 |
| 52-week low | ₹1,069.00 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 54.74% |
| FIIs | 5.74% |
| DIIs | 20.19% |
| Public | 19.32% |
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.